Literature DB >> 9120921

Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections.

F Haab1, P E Zimmern, G E Leach.   

Abstract

PURPOSE: We prospectively compared the efficacy of 2 bulking agents to treat incontinence related to intrinsic sphincter deficiency.
MATERIALS AND METHODS: A total of 67 women underwent periurethral injection for intrinsic sphincter deficiency at the same institution performed by 1 surgeon. Patients were divided into 45 who received fat (group 1) and 22 who received collagen (group 2) injections. Both groups were comparable for age, parity, number of previously failed procedures and number of pads used daily. Preoperative urodynamic evaluation revealed a low Valsalva leak point pressure in both groups (mean plus or minus standard deviation 23.82 +/- 12.41 versus 29.35 +/- 11.32, not significant). Patients rated the subjective degree of postoperative improvement as 0 to 100%.
RESULTS: At a mean followup of 7 months after the last injection only 13% of the fat group and 24% of the collagen group were cured. The mean percentage of subjective improvement was significantly greater in the collagen than in the fat group (70.9 +/- 28 versus 31.2 +/- 41.7%, respectively, p < 0.001). The failure rate was significantly greater in the fat group compared to the collagen group (p < 0.001).
CONCLUSIONS: Based on results of a prospective comparison of fat and collagen injection, collagen is more effective than fat for treatment of intrinsic sphincter deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120921

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  A new injectable bulking agent for treatment of stress urinary incontinence.

Authors:  Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 3.092

2.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

Review 3.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 4.  Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency.

Authors:  Christopher James Hillary; Nadir Osman; Christopher Chapple
Journal:  World J Urol       Date:  2015-06-10       Impact factor: 4.226

Review 5.  Treatment options for intrinsic sphincter deficiency.

Authors:  Sovrin M Shah; Geoffrey S Gaunay
Journal:  Nat Rev Urol       Date:  2012-10-02       Impact factor: 14.432

6.  Treatment options for stress urinary incontinence.

Authors:  Eric S Rovner; Alan J Wein
Journal:  Rev Urol       Date:  2004

7.  Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile.

Authors:  Lindsey A Kerr
Journal:  Rev Urol       Date:  2005

Review 8.  Treatment of stress urinary incontinence: recent developments in the role of urethral injection.

Authors:  Philip van Kerrebroeck; Flip ter Meulen; Elisabeth Farrelly; Gregor Larsson; Lena Edwall; Aino Fianu-Jonasson
Journal:  Urol Res       Date:  2003-01-30

9.  Where should bulking agents for female urodynamic stress incontinence be injected?

Authors:  Annette Kuhn; Werner Stadlmayr; Daniela Lengsfeld; Michel D Mueller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

10.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.